Neurodevelopmental disorders: topiramate increases the risk for children exposed in utero
The antiepileptic drug topiramate is of growing concern to health authorities. The Medicines Agency (ANSM) had already called for drastically restricting its use in pregnant women, it reiterates its recommendations in the face of even greater than estimated risks for the baby. The risk of occurrence of autism spectrum disorders would be multiplied by 2.77 …